NTC
North Tide Capital Portfolio holdings
AUM
$469M
1-Year Return
6.55%
This Quarter Return
+3.4%
1 Year Return
+6.55%
3 Year Return
+14.78%
5 Year Return
–
10 Year Return
–
AUM
$1.39B
AUM Growth
+$63.3M
(+4.8%)
Cap. Flow
+$67.2M
Cap. Flow
% of AUM
4.85%
Top 10 Holdings %
Top 10 Hldgs %
74.96%
Holding
28
New
8
Increased
3
Reduced
4
Closed
6
Top Buys
| 1 |
Teva Pharmaceuticals
TEVA
|
$88.7M |
| 2 |
Gilead Sciences
GILD
|
$58.5M |
| 3 |
SVU
SUPERVALU Inc.
SVU
|
$44.5M |
| 4 |
STJ
St Jude Medical
STJ
|
$36.5M |
| 5 |
Quest Diagnostics
DGX
|
$36.3M |
Top Sells
| 1 |
Boston Scientific
BSX
|
$79.9M |
| 2 |
Bausch Health
BHC
|
$49.7M |
| 3 |
GHDX
Genomic Health, Inc.
GHDX
|
$45.8M |
| 4 |
ESRX
Express Scripts Holding Company
ESRX
|
$43.4M |
| 5 |
Baxter International
BAX
|
$34.3M |
Sector Composition
| 1 | Healthcare | 83.39% |
| 2 | Consumer Discretionary | 3.6% |
| 3 | Technology | 3.41% |